4.6 Article

Wnt5a Induces a Tolerogenic Phenotype of Macrophages in Sepsis and Breast Cancer Patients

Journal

JOURNAL OF IMMUNOLOGY
Volume 188, Issue 11, Pages 5448-5458

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1103378

Keywords

-

Categories

Funding

  1. Swedish Cancer Foundation
  2. Medical Research Council
  3. Skane University Hospital Research Foundation
  4. Malmo Allmanna Sjukhus Cancer Foundation
  5. Gunnar Nilssons Cancer Foundation
  6. Ollie och Elof Ericssons Foundation
  7. Gyllenstierna Krapperup Foundation

Ask authors/readers for more resources

A well-orchestrated inflammatory reaction involves the induction of effector functions and, at a later stage, an active downregulation of this potentially harmful process. In this study we show that under proinflammatory conditions the noncanonical Wnt protein, Wnt5a, induces immunosuppressive macrophages. The suppressive phenotype induced by Wnt5a is associated with induction of IL-10 and inhibition of the classical TLR4-NF-kappa B signaling. Interestingly, this phenotype closely resembles that observed in reprogrammed monocytes in sepsis patients. The Wnt5a-induced feedback inhibition is active both during in vitro LPS stimulation of macrophages and in patients with sepsis caused by LPS-containing, Gram-negative bacteria. Furthermore, using breast cancer patient tissue microarrays, we find a strong correlation between the expression of Wnt5a in malignant epithelial cells and the frequency of CD163(+) anti-inflammatory tumor-associated macrophages. In conclusion, our data point out Wnt5a as a potential target for an efficient therapeutic modality in severe human diseases as diverse as sepsis and malignancy. The Journal of Immunology, 2012, 188: 5448-5458.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available